REPROSENT
Company

Last deal

$100K

Amount

Grant

Stage

08.08.2022

Date

2

all rounds

$225K

Total amount

date founded

Financing round

General

About Company
REPROSENT helps cancer patients collect and use their own symptom data to achieve better outcomes.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2020

Number of employees

Last funding type

Grant

IPO status

Private

Description

The company's mobile app accurately captures daily symptoms, producing reports that are sent to oncologists to improve communication with the medical team, reduce hospitalizations and ER visits, and increase overall survival. Founder Aimee DeGolyer's personal experience losing her father to an adverse reaction to cancer treatment drives REPROSENT's mission to improve outcomes for patients using their own data.
Contacts
Similar Companies
1000
Outcomes4Me

Outcomes4Me

Outcomes4Me develops a free mobile app and platform to navigate cancer treatment and care.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Machine Learning, Artificial Intelligence

Location

Boston, MA, USA

total rounds

2

total raised

$16.7M
Vinehealth

Vinehealth

Vinehealth is an AI-driven platform that improves the quality of life and survival of cancer patients.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Artificial Intelligence, Biotechnology

Location

London, UK

total rounds

8

total raised

$11.04M
Daybuilder

Daybuilder

Daybuilder is a web-based platform that helps patients with chronic illnesses by providing self-monitoring and data visualization tools.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Software

Location

Copenhagen, Denmark
MOXYTECH

MOXYTECH

MoxyTech improves patients' quality of life by revolutionizing pain care through advanced technologies.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Analytics, Software

Location

Ann Arbor, MI, USA

total rounds

1

total raised

$300K

Financials

Funding Rounds
2
2

Number of Funding Rounds

$225K

Money Raised

Their latest funding was raised on 08.08.2022. Their latest investor Astellas Oncology C3 Prize. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Astellas Oncology C3 Prize

Astellas Oncology C3 Prize

Astellas Oncology supports cancer care innovation beyond medicine.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

count Of Investments

1
Y Combinator

Y Combinator

Y Combinator is a startup fund and program that invests in a large number of startups twice a year.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Location

Mountain View, CA, USA

total rounds

2

total raised

$1.5B

count Of Investments

6558

count Of Exists

588
Co-Investors
Investors
2
2

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
Astellas Oncology C3 Prize

Astellas Oncology C3 Prize

Astellas Oncology supports cancer care innovation beyond medicine.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

count Of Investments

1
Y Combinator

Y Combinator

Y Combinator is a startup fund and program that invests in a large number of startups twice a year.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Location

Mountain View, CA, USA

total rounds

2

total raised

$1.5B

count Of Investments

6558

count Of Exists

588

People

Founders
2
Mike Sample
Mike Sample

Mike Sample

Mike Sample is the Co-founder & CTO at REPROSENT.

current job

REPROSENT
REPROSENT

organization founded

1

Mike Sample

Aimee DeGolyer

Aimee DeGolyer is the Co-Founder & CEO at REPROSENT.

current job

REPROSENT
REPROSENT

organization founded

1

Aimee DeGolyer

Employee Profiles
2
Mike Sample

Mike Sample

Co-founder & CTO

Aimee DeGolyer

Co-Founder and CEO

Activity

Recent News
0